Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03637543
Title Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Beth Israel Deaconess Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
St. Elizabeth's Medical Center Boston Massachusetts 02135 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
DFCI South Shore South Weymouth Massachusetts 02190 United States Details
DFCI Londonderry Londonderry New Hampshire 03053 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field